LATEST UPDATES » Vol 25, No. 04, April 2021 – The Evolution of Medicine – Exploring the Contributions of Sony’s Technology       » Potential Target and Neural Circuitry for Psychiatric Conditions       » Study Provides Insight to Cause of Coral Necrotic Death       » Combination of X-Rays and AI for Quicker Diagnosis of COVID-19       » Clinical Study Achieves Goals in Diagnosing Rare Childhood Disorders       » Portable Device to Detect Plant Stress      
Vol 25, No. 03, March 2021   |   Issue PDF view/purchase
Singapore National Eye Centre Collaborates with NCS to Improve Operational Efficiency
Allecra Therapeutics and Shanghai Haini Pharmaceutical announce exclusive licensing agreement for the manufacture, development and commercial rights of cefepime/enmetazobactam in China.

The Singapore National Eye Centre (SNEC) has partnered with NCS to design, build, and deploy a new Appointment Scheduling Optimiser (ASO) to transform clinic operations, reduce patient waiting times and allocate manpower and resources more efficiently. The ASO taps on NCS NEXT’s expertise in artificial intelligence (AI), advanced analytics, deep learning, and machine learning technology with the goal of addressing operational challenges and resourcing.

The ASO is scheduled for rollout in the fourth quarter of 2021 and is planned for further scaling and deployment across all SingHealth institutions to improve overall clinic operational efficiency, elevating patient satisfaction and experience. Annually, SNEC manages a workload of 360,000 patient visits in its Specialist Outpatient Clinics.

Ms Charity Wai, Chief Operating Officer, SNEC said, “Currently, appointment scheduling for all patient visits including those requiring initial consultations and the necessary same-day eye services and investigations is a time and labour-intensive process handled by appointment staff. To address the growing volume of appointment requests and limited visibility over demand at multiple service stations resulting in bottlenecks and long clinic waiting times, SNEC collaborated with NCS to leverage the Appointment Scheduling Optimiser to resolve the various pain points.”

NCS will deploy advanced data and predictive analytics as well as machine learning to tailor an in-house schedule optimisation ASO platform. Using SNEC data sets with exact patient and operational requirements, AI algorithms perform supply-demand matching and appointment schedule optimisation is done continuously and incrementally with minimal human intervention, until an optimal daily schedule is reached, matching confirmed patient appointments with all available clinical resources.

Mr Howie Sim, Vice President, Healthcare & Transport Client Service Unit, NCS said, “We are delighted with this opportunity to work with SNEC to play a critical role in the digitalisation of healthcare services that will have a tangible impact on the end-to-end patient journey. The first-of-its-kind in Singapore, the Appointment Scheduling Optimiser marks the first of many use cases in healthcare, such as the improved allocation of hospital beds, operating theatres, and even optimising valuable nurse-to-patient staffing for better care. The Appointment Scheduling Optimiser is an example of how digitalisation of business operations can revolutionise customer outcomes.”

The ASO operates on NCS’ proprietary Enterprise Schedule Optimisation Platform which offers the opportunity to scale the capabilities of the smart scheduling solution, offering businesses in a range of industries beyond the healthcare sector greater flexibility to customise solutions to better suit their needs. The ASO will leverage data analytics to better predict future resourcing demand, enhance optimisation and improve long-term resource allocation as well as operational efficiency.

news Commemorating World Health Day with Viatris
news Entire industrial chain resources of advanced medical equipment are lining up at Medtec China 2021
news CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021
news Highlights from the E&L China 2020 Conference

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy